About Celon Laboratories
Celon Laboratories is a company based in Hyderabad (India) founded in 2007 by Ravindra K V and Vimal Kavuru was acquired by Development Partners International in November 2020. Celon Laboratories has raised $61.41 million across 7 funding rounds from investors including European Union, British International Investment and Eight Roads Ventures. The company has 535 employees as of November 15, 2024. Celon Laboratories offers products and services including Oncology Products and Critical Care Products.
- Headquarter Hyderabad, India
- Employees 535 as on 15 Nov, 2024
- Founders Ravindra K V, Vimal Kavuru
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Celon Laboratories Private Limited
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$20.99 M (USD)40.35as on Mar 31, 2018
-
Net Profit
$2.49 M (USD)1234.74as on Mar 31, 2018
-
EBITDA
$2.81 M (USD)121.35as on Mar 31, 2018
-
Total Equity Funding
$61.41 M (USD)
in 7 rounds
-
Latest Funding Round
$25.66 M (USD), Series B
Jun 17, 2016
-
Investors
European Union
& 13 more
-
Employee Count
535
as on Nov 15, 2024
-
Acquired by
Development Partners International
(Nov 18, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Celon Laboratories
Celon Laboratories offers a comprehensive portfolio of products and services, including Oncology Products and Critical Care Products.
Formulations for cancer treatment are developed and marketed in niche areas.
Products for cardiovascular and anesthesia segments are provided to support patient care.
People of Celon Laboratories
Unlock access to complete
Unlock access to complete
Funding Insights of Celon Laboratories
Celon Laboratories has successfully raised a total of $61.41M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $25.66 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Celon Laboratories
Celon Laboratories has secured backing from 14 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include European Union, British International Investment and Eight Roads Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Government agency focused on small and medium-sized businesses
|
Locked | Locked | Locked |
Investor details for Celon Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celon Laboratories
Investment portfolio details for Celon Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celon Laboratories
Detailed financials for Celon Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celon Laboratories Comparisons
Peer comparison for Celon Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celon Laboratories
Detailed competitors of Celon Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celon Laboratories
Complete news archive for Celon Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celon Laboratories
Celon Laboratories was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Celon Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Ravindra K V is the current CEO of Celon Laboratories. They have also founded this company.
Celon Laboratories is a funded company, having raised a total of $61.41M across 7 funding rounds to date.
As of Nov 15, 2024, the latest employee count at Celon Laboratories is 535.
Annual revenue of Celon Laboratories is $20.99M as on Mar 31, 2018.
Celon Laboratories was established in 2007 in Hyderabad, India, focusing on the pharmaceutical sector. Products in oncology, anti-infective, and critical care areas are developed, manufactured, and marketed, including tablets, capsules, ampoules, vials, pre-filled syringes, and emulsion injections. Contract research and manufacturing services are offered, encompassing formulation development, lyophilization, quality control testing, stability studies, and regulatory support. Markets served include the Asia Pacific, Africa, Latin America, CIS countries, and Eastern Europe.
Celon Laboratories offers Oncology Products and Critical Care Products.
Celon Laboratories has 14 investors. Key investors include European Union, British International Investment, Eight Roads Ventures, My Home Labs, and Sequoia Capital.
The valuation of Celon Laboratories is $54.48M as of Jun 2016.